These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7654449)

  • 61. Antisense oligonucleotides as therapeutics for malignant diseases.
    Ho PT; Parkinson DR
    Semin Oncol; 1997 Apr; 24(2):187-202. PubMed ID: 9129689
    [TBL] [Abstract][Full Text] [Related]  

  • 62. An antisense oligonucleotide primer.
    Hogrefe RI
    Antisense Nucleic Acid Drug Dev; 1999 Aug; 9(4):351-7. PubMed ID: 10463079
    [No Abstract]   [Full Text] [Related]  

  • 63. Antisense strategies for oncogene inactivation.
    Stein CA; Benimetskaya L; Mani S
    Semin Oncol; 2005 Dec; 32(6):563-72. PubMed ID: 16338422
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Progress of gene therapy in pancreatic carcinoma].
    Liang Z; Liu T
    Zhonghua Bing Li Xue Za Zhi; 2002 Dec; 31(6):548-50. PubMed ID: 12760344
    [No Abstract]   [Full Text] [Related]  

  • 65. Cancer therapy using oligonucleotide-based STAT3 inhibitors: will they deliver?
    Kortylewski M; Nechaev S
    Ther Deliv; 2014 Mar; 5(3):239-42. PubMed ID: 24592948
    [No Abstract]   [Full Text] [Related]  

  • 66. MicroRNA-based therapeutics for cancer.
    Wang V; Wu W
    BioDrugs; 2009; 23(1):15-23. PubMed ID: 19344188
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Antisense strategy in malignant brain tumours treatment.
    Trojan LA; Pan Y; Szpechcinski A; Ly A; Kopinski P; Chyczewski L; Kasprzak H; Donald A; Trojan J
    Rocz Akad Med Bialymst; 2004; 49 Suppl 1():94-7. PubMed ID: 15638387
    [No Abstract]   [Full Text] [Related]  

  • 68. Development of Novel Therapeutic Agents by Inhibition of Oncogenic MicroRNAs.
    Nguyen DD; Chang S
    Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29280958
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Prospects for antisense therapy].
    Maekawa T
    Rinsho Ketsueki; 1995 May; 36(5):410-8. PubMed ID: 7783344
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Anti-sense and gene therapy approaches to the treatment of lymphomas.
    Devereux S; Cotter FE
    Baillieres Clin Haematol; 1996 Dec; 9(4):819-34. PubMed ID: 9138619
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Comparative Renal Toxicopathology of Antisense Oligonucleotides.
    Engelhardt JA
    Nucleic Acid Ther; 2016 Aug; 26(4):199-209. PubMed ID: 26983026
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Slivers of the spectrum.
    Branca M
    Nat Biotechnol; 2021 May; 39(5):540-545. PubMed ID: 33888895
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Doubts About Therapy for Neurological Diseases With Antisense Oligonucleotides.
    Bhagavati S
    JAMA Neurol; 2016 Dec; 73(12):1502. PubMed ID: 27802491
    [No Abstract]   [Full Text] [Related]  

  • 74. Doubts About Therapy for Neurological Diseases With Antisense Oligonucleotides-Reply.
    Corey DR
    JAMA Neurol; 2016 Dec; 73(12):1502-1503. PubMed ID: 27802484
    [No Abstract]   [Full Text] [Related]  

  • 75. Toward genetically targeted research and therapeutics.
    Hawkins JW; Krieg AM
    Antisense Res Dev; 1992; 2(3):185. PubMed ID: 1490069
    [No Abstract]   [Full Text] [Related]  

  • 76. Gene therapy for cancer.
    Gore ME; Collins MK
    Eur J Cancer; 1994; 30A(8):1047-9. PubMed ID: 7654426
    [No Abstract]   [Full Text] [Related]  

  • 77. Gene therapy in gestation.
    Corcoran E
    Sci Am; 1988 Nov; 259(5):135-6. PubMed ID: 3212440
    [No Abstract]   [Full Text] [Related]  

  • 78. Protein delivery of caspase-3 induces cell death in malignant C6 glioma, primary astrocytes and immortalized and primary brain capillary endothelial cells.
    Zassler B; Blasig IE; Humpel C
    J Neurooncol; 2005 Jan; 71(2):127-34. PubMed ID: 15690127
    [TBL] [Abstract][Full Text] [Related]  

  • 79. European School of Oncology Task Force Papers: gene therapy--a future in cancer management? Antisense therapy for malignant disease.
    O'Brien SG; Kirkland MA; Goldman JM
    Eur J Cancer; 1994; 30A(8):1160-4. PubMed ID: 7654449
    [No Abstract]   [Full Text] [Related]  

  • 80. Antisense oligonucleotides as therapeutic agents.
    Alama A; Barbieri F; Cagnoli M; Schettini G
    Pharmacol Res; 1997 Sep; 36(3):171-8. PubMed ID: 9367660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.